Latest Investor Confidence News

Kali Metals has raised $7 million through a share placement to fund further exploration at its promising Marble Bar Gold Project and lithium assets in Higginsville. The capital injection underscores investor confidence in the company’s growth strategy.

Terragen Holdings has raised A$7 million through a strategic equity raising to fund scientific research and accelerate global commercialisation, while appointing Dr Michele Allan AO as its new Chair.

Pursuit Minerals has successfully completed the first tranche of a $7 million placement, issuing nearly 47 million shares at 9.5 cents each, with a second tranche and incentive options pending shareholder approval.

Discovery Alaska Limited has completed a $354,000 private placement to fund exploration at its Boulder Creek Gold-Silver Project in Idaho, with additional project opportunities under review.

Apollo Minerals welcomes a $2.8 million investment from Tribeca Investment Partners, marking a significant vote of confidence in its Couflens tungsten-gold project in southern France. This capital injection follows a recent $6.5 million raise and aims to accelerate exploration and development activities.

American Uranium has restarted drilling at its Lo Herma ISR uranium project in Wyoming, aiming to expand and upgrade its existing 8.57 million pound resource ahead of key updates in 2026.

Codeifai Limited has raised $1.1 million through a share placement that coincided with a sharp increase in its share price, confirming full compliance with ASX disclosure rules following a detailed inquiry.

Elanor Commercial Property Fund members have voted to replace Elanor Funds Management Limited with Evolution Trustees Limited as the responsible entity, marking a significant governance shift now officially recorded by ASIC.

PYC Therapeutics has successfully closed a $537 million institutional placement and entitlement offer, positioning the company to raise at least $600 million to advance its RNA-based therapies targeting genetic diseases.

Krakatoa Resources has raised $1.25 million through a well-supported placement to fund the next phase of exploration at its high-grade Zopkhito Antimony-Gold Project, following promising drilling results that validate historic data.

Island Pharmaceuticals has raised $9 million to advance its antiviral drug Galidesivir through the FDA’s Animal Rule pathway, targeting inclusion in the US Strategic National Stockpile for biodefense viruses.

Centuria Office REIT has delivered a strong half-year performance with increased portfolio valuation and reaffirmed full-year guidance, while strategically divesting a key asset at a premium.